| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-17 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |